Qualifications Primary Qualification: MEDICAL DOCTOR UNIVERSITY OF TORINO ( ITALY) IN 1980 Specialist Qualification: 1) GENERAL MEDICINE UNIVERSITY OF TURIN 1) ONCOLOGY UNIVERSITY OF TORINO ( ITALY) 1985 2) GASTROINTESTINAL ENDOSCOPY AND SURGERY OF THE GASTROINTESTINAL TRACT UNIVERSITY OF MILAN ( ITALY) 1990 3) PHD IN RIGS ( RADIO-IMMUNE-GUIDED SURGERY) UNIVERSITY OF TORINO ( ITALY) 1997. 1980-1981 MEDICAL TRAINING IN INTERNAL MEDICINE UNIVERSITY OF TORINO S. GIOVANNI HOSPITAL TORINO 1982-1985 TRAINING DURING SPECIALIZATION IN ONCOLOGY UNIVERSITY OF TORINO SAN GIOVANNI HOSPITAL A.S. 1985-1990 TRAINING DURING SPECIALIZATION IN SURGERY OF THE GASTROINTESTINAL TRACT AND GASTROINTESTINAL ENDOSCOPY OSP. MAGGIORE PAD. MONTEGGIA UNIVERSITY OF MILAN 1990-1993 SPECIAL ASSISTANT DEPT. OF ONCOLOGICAL DISEASES AT THE UNIVERSITY OF TORINO ( ITALY) AT MOLINETTE HOSPITAL 1993-TILL NOW NOW PROFESSOR OF GASTROINTESTINAL ENDOSCOPY AT THE UNIVERSITY OF TORINO SCHOOL OF MEDICINE SINCE 1997 HE IS IN CHARGE OF THE ENDOSCOPY UNIT AT THE DEPT. OF SURGICAL ONCOLOGY AT THE UNIVERSITY OF TORINO SINCE 1998 HE IS UNIVERSITY BOARD TUTOR FOR STATE LICENCE EXAMINATION IN 2002 HE OBTAINED A PHD IN RIGS ( RADIO-IMMUNE GUIDED SURGERY ) AT THE UNIVERSITY OF TURIN PROFESSOR IN CHARGE OF THE ENDOSCOPY AND G.I. UNIT, UNIVERSITY HOSPITAL AT MOLINETTE TURIN ITALY HE AND HIS TEAM PERFORM OVER 1500 UPPER AND LOWER G.I. PROCEDURES INCLUDING MORE THAN 350 E.P. AND SEE OVER 1300 OUTPATIENTS INCLUDING NEW CASES, FOLLOW UPS AND MORE THAN 600 INPATIENTS PER YEAR Current employment

I have studied pharmacy with a partial focus on medicine and pursued advanced training over the years in the fields of genetics and cancer immunology. I am here to assist you in finding the best cancer therapy worldwide and guide you from your initial inquiry to the completion of the treatment. With 25 years of experience in Big Pharma and as the director of specialized clinics in Dubai, I have had the privilege of working alongside dedicated physicians and scientists who have successfully developed innovative cancer therapies. Today, I take pride in having them as part of our Iaso Cancer Initiative. Bruno Rosset